FDA Warns of Stroke, Death With Off-Label Use of Wingspan Stent FDA Warns of Stroke, Death With Off-Label Use of Wingspan Stent

Postmarket data show a significantly increased risk of stroke or death when the Wingspan intracranial stent system is used outside the approved indications.News Alerts
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Neurology & Neurosurgery News Alert Source Type: news